Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Integrin function in chronic lymphocytic leukemia

A M Vincent1, J C Cawley, J Burthem

  • 1Department of Haematology, Royal Liverpool University Hospital, Liverpool, UK.

Blood
|June 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inverted channel variations identified on a distal portion of a bajada in the central Atacama Desert, Chile.

Geomorphology (Amsterdam, Netherlands)·2021
Same author

Peripheral markers of oxidative stress in Labrador retrievers with copper-associated hepatitis.

The Journal of small animal practice·2021
Same author

Evaluation of the use of rotational thromboelastometry in the assessment of FXI deficency.

Haemophilia : the official journal of the World Federation of Hemophilia·2017
Same author

Evaluation of the use of global haemostasis assays to monitor treatment in factor XI deficiency.

Haemophilia : the official journal of the World Federation of Hemophilia·2016
Same author

Monocytes/Macrophages Stimulate Hairy-Cell Proliferation.

Leukemia & lymphoma·2016
Same author

In vitro comparison of the effect of two factor XI (FXI) concentrates on thrombin generation in major FXI deficiency.

Haemophilia : the official journal of the World Federation of Hemophilia·2015
Same journal

Fibrocytes drive JAK2V617F-mutated myelofibrosis: pitavastatin reverses marrow fibrosis and anemia.

Blood·2026
Same journal

Identifying steroid-refractory aGVHD before it happens.

Blood·2026
Same journal

ELISA-negative HIT: antibody recognition and relevance.

Blood·2026
Same journal

EBV and immunodeficiency: the odd couple drawn to the brain.

Blood·2026
Same journal

A bone to pick with ferric carboxymaltose.

Blood·2026
Same journal

A step toward streamlining HIT diagnosis.

Blood·2026
See all related articles

Integrin function, not just expression, influences chronic lymphocytic leukemia (CLL) cell behavior. Activated CLL cells show increased adhesion and migration, impacting disease patterns.

Area of Science:

  • Immunology
  • Hematology
  • Cell Biology

Background:

  • Integrins mediate lymphocyte tissue localization.
  • Understanding integrin function in chronic lymphocytic leukemia (CLL) is crucial for disease behavior insights.

Purpose of the Study:

  • To investigate how integrin function, beyond mere expression, dictates disease progression in CLL.
  • To analyze the role of integrin-mediated adhesion and migration in CLL pathogenesis.

Main Methods:

  • Fluorescence-activated cell sorting (FACS) and immunoprecipitation to determine integrin expression profiles in CLL patients.
  • Assays to assess CLL cell adhesion to endothelium and extracellular matrix proteins.
  • Evaluation of CLL cell migration through endothelial/stromal barriers.

Related Experiment Videos

Main Results:

  • CLL cells express specific integrin heterodimers, with variable expression of alpha chains.
  • CLL cells exhibit low-level binding to unstimulated endothelium via alpha L beta 2/ICAM, but enhanced binding to stimulated endothelium via alpha 4 beta 1/VCAM-1 in a subset of patients.
  • Adhesion to fibronectin is variable, with no significant binding to basement membrane components.
  • Activated CLL cells demonstrate increased adhesion and migratory capacity, particularly after cytokine stimulation.

Conclusions:

  • Integrin expression and function are critical determinants of CLL cell behavior and tissue homing.
  • The activation state of CLL cells and their response to cytokines significantly influence their adhesive and migratory capabilities.
  • These factors collectively contribute to the diverse clinical manifestations observed in CLL patients.